Tag Archives: Announces

ADDClasses.com Announces Special Q&A Teleseminar with Dr. Edward Hallowell

August 11, 2012     No comments


Plymouth, MA (PRWEB) February 9, 2011

ADDClasses.com director Tara McGillicuddy is pleased to announce that ADD / ADHD expert, Dr. Ned Hallowell is offering a free teleseminar based on registered attendees questions. The teleseminar will be held on Tuesday, February 15, 2011 at 8:00 p.m. Eastern Time. The teleseminar is open to the public and is free of charge. Registrants for the teleseminar can participate via the web or using the telephone from anywhere in the world. Participants will also be given a chance to submit questions in advance – and exceptional opportunity to “pick the brain” of this world renowned expert.

Edward (Ned) Hallowell, M.D., a child and adult psychiatrist and graduate of Harvard College and Tulane Medical School, is the founder of The Hallowell Centers in Sudbury, Massachusetts and New York City. He was a member of the Harvard Medical School faculty from 1983 until he retired from academics in 2004 to devote his full professional attention to his clinical practice, lectures, and the writing of books. He has authored eighteen books on various psychological topics, including attention deficit disorder, the power of the human connection, the childhood roots of happiness in life, methods of forgiving others, dealing with worry and managing excessive busyness. Dr. Hallowell’s newest book,SHINE: Using Brain Science to Bring out the Best in Your People was published by Harvard Business School Press in January 2011.

Dr. Hallowell is a highly recognized speaker around the world and has presented to thousands on topics such as ADD, strategies on handling your fast-paced life, the Childhood Roots of Adult Happiness and other pertinent family and health issues. He has been featured on 20/20, 60 Minutes, Oprah, PBS, CNN, The Today Show, Dateline, Good Morning America, The View and many more. He has been interviewed for The New York Times, USA Today, Newsweek, Time Magazine, U.S. News and World Report, USA Weekend, the Los Angeles Times, the Boston Globe and many, many more.???Finally, he is a regular columnist for ADDitude Magazine.

ADDClasses.com is a virtual support and education resource helping people affected by Attention Deficit Disorder lead happier and more productive lives. ADDClasses.com was founded in 2004 by ADHD Support Mentor and Coach Tara McGillicuddy. For the past several years ADDClasses.com has been leading they way offering accessible virtual programs for adults with Attention Deficit Disorder. In addition to offering quality programs for adults, ADDClasses.com also offers programing to support parents of children with Attention Deficit Disorder.

Registration information for this free teleseminar can be found at http://www.addclasses.com.

###







Read More

Simul TV Announces Agreement With American Music Channel and Its CEO Hal Willis, Former CMT Chief, For Exclusive Social TV Channels

August 10, 2012     No comments


Virginia (PRWEB) June 19, 2012

The American Music Channel has agreed to create a series of exclusive music channels for Simul TV, which will boast an impressive lineup of live and video-on-demand content. The beta version [Simul TV] will focus on family entertainment programs, and a healthy mix of comedy, action, and a 24/7 live sports feed. The American Music Channel will provide a variety of channels selected from among a number of musical genres, including live streaming concerts, with a special focus on emerging and independent artists. Simul TV?s revolutionary technology allows viewers to engage with their favorite video entertainment like never before, blending the traditional television experience with mobile media to create a social TV interaction.

IMN?s CEO and Founder Steven Turner said, ?Simul TV is about bringing people together, connecting fans of all types of entertainment, simultaneously sharing streaming content while communicating through picture-in picture video chats, voice chats and text chats. Music is the ideal format for social television, and with Hal?s impeccable reputation as a visionary in the media industry, he and American Music Channel are the perfect partners to assist Simul TV in bringing this revolutionary technology to the music fan and the emerging artist.?

The American Music Channel?s CEO and Founder Hal Willis added, ?I started down this road more than ten years ago, with a passion for utilizing technology to build a new model for the music business and a viable platform for the emerging artist. We have been very active in the Web and social media arenas since the inception of online streaming video across connected devices, all the while keeping our eye on possibilities for Internet TV. Steven first approached me several years ago, and I am delighted to see his vision come to fruition and allow us to take ours to the next level.?

Interconnect Media Network Systems (IMN) is a Virginia-based media company. It specializes in video ingestion and encoding, as well as HD and SD transcoding and delivery using adaptive bitrate streaming. IMN has both hardware and cloud based services as well as a full line of products that will seamlessly integrate with broadcast workflow.

American Music Channel is a destination portal and social media platform for all things music, counting agreements with all of the major record labels among one of the largest libraries of music videos on the Web. The company has been named to the Business TN ?Hot 100? and Nashville Post ?Fast 50? lists of emerging companies. Mr. Willis?s leadership roles at CMT and CMT Europe followed a long career as General Counsel for The Nashville Network and Acuff-Rose Music. On the heels of having founded mPhase Technologies, which in conjunction with the Georgia Tech Research Institute was a pioneer in the delivery of digital video over copper telephone lines, Willis launched American Music Channel in April 2000. Patty Silver, President and Chief Creative Officer, is a nationally renowned consultant, facilitator, and speaker, as well as an award-winning documentary filmmaker and a jurist for the New York Film Festival. As a therapist she was founder and CEO of the not-for-profit Shekhinah Center Breast Cancer Help Program.







Find More Breast Cancer Press Releases

Read More

CHN PPO Announces Partnership with Barnabas Health Corporate Care

August 09, 2012     No comments


Hamilton, NJ (PRWEB) August 08, 2012

Consumer Health Network PPO (CHN PPO), a URAC-accredited network of over 125,000 health care providers, today announced an expanded partnership with Barnabas Health. Under a new agreement, Barnabas Health Corporate Care will join the CHN PPO Network, which already includes Saint Barnabas Medical Center, Clara Maass Medical Center, Kimball Medical Center, Community Medical Center, Newark Beth Israel Medical Center, and Monmouth Medical Center as participating hospitals. CHN PPO is a division of Consolidated Services Group (CSG), a technology-driven, clinically-based medical claims management provider.

This new partnership will significantly strengthen CHN PPO?s specialized provider network, which is focused on delivering the highest quality care and achieving the best possible outcomes for people injured in workplace and automobile accidents.

As part of New Jersey’s largest integrated health system, Barnabas Health Corporate Care offers comprehensive occupational health and wellness programs. Services are delivered under the direction of board-certified, fellowship-trained specialists in occupational medicine to ensure timely treatment and recovery after work-related injury, and to keep employees healthy year-round.

?CHN PPO enjoys a strong partnership with Barnabas Health and we are excited to add these stellar corporate care facilities to our provider network,? said Michael A. Morrone, CSG founder and president. ?Adding providers highly skilled in diagnosing and treating workplace injuries will support our continued expansion in the national workers? compensation marketplace.?

Each provider in CHN?s network undergoes a rigorous credentialing process, including a re-credentialing process every three years in accordance with URAC standards. Specialties include but are not limited to primary care, occupational medicine, orthopedics, physical therapy, trauma centers and urgent care facilities throughout the Northeastern United States. CHN also offers access to PPO services nationwide through a network of PPO affiliates.

For Barnabas Health Corporate Care, the partnership will provide access to the growing list of workers? compensation policyholders served by the CHN PPO network.

?Barnabas Health continually seeks partnerships with organizations that enhance access for patients to our high quality services close to home in their respective community,? said Joe Hicks, president and chief executive officer of Barnabas Health Behavioral Health Network and Barnabas Health Corporate Care. ?We look forward to putting Barnabas Health?s expertise and breadth and depth of services to work for the members of CHN PPO.?

###

About CHN

CHN PPO, a division of Consolidated Services Group, Inc. (CSG), is a leading preferred provider organization serving the northeastern United States with a premier, URAC-accredited network of over 125,000 health care providers. For over 20 years, CHN has provided PPO networks for insurance carriers, TPAs, joint insurance funds, counties, municipalities and school boards. Through our parent company, CSG, we provide a complete, integrated medical claims solution, including seamless collaboration through our proprietary medlogix? technology; clinically-based recommendations through our highly skilled medical staff; and access to a nationwide network of premier health care providers. CSG?s powerful mix of medical expertise, proven processes and innovative technology delivers a more efficient, disciplined insurance claims process. The result is reduced severity, lower overhead and increased productivity for the clients we serve. Visit http://www.chn.com to learn more.

About Barnabas Health

Barnabas Health is the largest not-for-profit integrated healthcare delivery system in New Jersey and one of the largest in the nation, annually caring for more than two million patients and delivering more than 18,000 babies. The system includes six acute care hospitals, two children?s hospitals, a free-standing behavioral health center, ambulatory care centers, geriatric centers, the state?s largest behavioral health network and comprehensive homecare and hospice programs. Among nationally recognized services are burn treatment; adult and pediatric cardiac surgery; heart, lung, kidney and pancreas transplant; neurology and neurosurgery; reproductive medicine and science; geriatrics; oncology; pediatrics; and women?s services. Barnabas Health includes 18,200 employees, (the second largest private employer in New Jersey); 4,600 physicians (one-fifth of the actively practicing physicians in New Jersey); and 445 residents and interns. For more information, log on to the web site at http://www.barnabashealth.org.







Read More

ShortStack Announces the Ability to Embed Custom Facebook Apps on Websites and Blogs

August 08, 2012     No comments


Reno, Nev. (PRWEB) August 07, 2012

ShortStack has announced an external embed feature that allows users to embed their custom apps on websites outside of Facebook. Businesses and individuals can now ?ShortStack Anywhere? using the custom Facebook app designer to increase Page likes and fan engagement.

?People are social outside of Facebook and we wanted businesses to be able to use our powerful tools anywhere they wanted.? Jim Belosic, CEO of ShortStack said. ?With external embedding, businesses can connect with their customers and fans other places on the web, and people can participate in apps, contests, and data collection beyond Facebook.?

ShortStack?s external embed feature requires that a user first installs the app on Facebook, and then they are able to install the same app, including all of its functions, on any web URL such as their blog or company website.

Businesses can adjust the height and width of a custom app to better suit their web page, and can restrict the app from being embedded on any additional web sites that have not been approved. External embed is similar to ShortStack?s mobile feature, which brings the app outside of the Facebook platform but still allows users to interact with the app as if they were viewing it on a Facebook Page. ShortStack provides a guide on their external embed feature here: External Embed with ShortStack

Currently, the external embed feature is available to ShortStack users who are on a paid plan of $ 75 a month or higher. ShortStack?s plans begin at free for users who have less than 2,000 Facebook fans, and run up to $ 300 a month depending on number of fans and the features businesses are looking for. Businesses and individuals can learn more about ShortStack?s pricing plans and features by visiting http://www.shortstack.com/pricing.

About ShortStack

ShortStack is a self-service web application design tool that allows individuals and businesses to create custom Facebook apps for their Facebook Pages. The dynamic platform contains more than 30 widgets and applications where users can integrate fan-gates, contests, sweepstakes, RSS feeds, Twitter, YouTube, and MailChimp newsletter signups that maximize their social media presence and potential. Custom Facebook apps designed using ShortStack are viewable via a mobile device or PC. To learn more about ShortStack visit http://www.shortstack.com.







Find More ADD Press Releases

Read More

In Response to Recent Survey on a Natural Remedy for ADHD, NourishLife Announces a Free Sample Give-Away

August 08, 2012     No comments


Lake Forest, IL (Vocus) May 6, 2008

A recent survey conducted by NourishLife revealed that less than half of the participants were aware of a link between nutrition and Attention Deficit Hyperactivity Disorder (ADHD) in children, and fewer than 30% of those polled were aware that most children with ADHD have a deficiency in omega-3. Omega-3 has been proven to be a natural remedy for ADHD.

Recent research indicates that compared to other children, children with focus and behavior issues have lower levels of omega-3s, and supplementation increases these to healthy levels. After omega-3 supplementation, children have exhibited reduced anxiety and impulsivity while also showing improved test scores, improved concentration, and improved reading ability. Approximately 8% of American children (4.4 million) have been diagnosed with ADHD according to current estimates. Symptoms of ADHD include problematic behavior, hyperactivity, child anxiety, and child depression.

“In our polling, we found that the majority of current omega-3 consumers were oblivious to the connection between ADHD and nutrition. Unfortunately, we were not surprised that so few people were aware of the omega-3 deficiency that exists in most hyperactive children,” said Kara Bolton, Communications Manager at NourishLife. “Even health-conscious consumers, like those who buy our PharmaOmega supplements, are unaware that there is a natural remedy for ADHD.”

“With over 20 million prescriptions written each year for ADHD treatment, we are determined to let people know that while drugs may address the symptoms of ADHD, omega-3 can address some of the underlying causes,” said Jason Way, VP of Customer Experience. “Omega-3 fats are nutrients, not drugs. And, unlike pharmaceuticals, there are additional health benefits with omega-3s, not side effects. By providing free samples of PharmaOmega Learn, we can help eradicate the omega-3 deficiency in children and provide a natural alternative to Ritalin.”

Learn has been specifically formulated for school-aged children. To receive a free sample of Learn, go to pharmaomega.com.

About NourishLife:

NourishLife (http://www.NourishLifePPP.com) is contributing to a major improvement in health and wellness by addressing nutritional deficiencies. The firm expects to help significantly reduce healthcare costs. Founded by nutrition industry veterans, the firm employs expert scientists and nutritionists passionate about health.

The PharmaOmega division of NourishLife (http://www.PharmaOmega.com) is the web’s premier source of Omega-3 information, research, and news. PharmaOmega creates specialty Omega-3 nutrition products of the highest concentration, quality, and purity.

NourishLife is a privately held company located in the Chicago area.

###







More Attention Deficit Hyperactivity Disorder Press Releases

Read More

PsychoGenics Announces Positive Phase-IIa for Its First-in-Class Partial 5-HT1A ? 5-HT1B Receptor Agonist in ADHD : Statistically Significant Reductions in the ADHD RS IV in Adult Patients

August 08, 2012     No comments


TARRYTOWN, N.Y. (PRWEB) June 2, 2008

The compound achieved a reduction in the ADHD-RS-IV total score of 42% from baseline compared to placebo (p

Further analysis showed that a subset of patients, who shared higher screening and baseline scores at the beginning of the study, exhibited an even greater response to treatment in the ADHD-RS-IV total score (p

Eltoprazine was well tolerated in this study and there were no serious adverse events. The most commonly reported treatment-emergent adverse events were related to GI-distress (nausea, constipation, diarrhea, pain) and fatigue and were usually mild or moderate in severity.

Based on these results, PsychoGenics plans to initiate further Phase-II studies in adults and children with ADHD.

“There is a need for a range of ADHD treatments, including novel stimulants and non-stimulant treatments so that patients can receive individualized and optimal care,” stated Dr. Lenard Adler, Associate Professor of Psychiatry, Neurology and Child & Adolescent Psychiatry, NYU Langone Medical Center.

Dr. Sharon Wigal, Clinical Professor of Pediatrics and Director of Clinical trials at University of California, Irvine Child Development Center, a well-published author on ADHD and one of the investigators in this trial, said, “The responses observed in this clinical trial are promising, and clearly indicate that eltoprazine is worthy of further study.”

About Eltoprazine

Unlike currently marketed medications for ADHD, eltoprazine is neither a psychostimulant nor a monoamine reuptake blocker. Eltoprazine was licensed from Solvay Pharmaceuticals where it had been previously studied for the treatment of pathological aggression. Solvay had studied numerous patients and healthy volunteers and showed that the compound was well tolerated at the doses employed in this trial. PsychoGenics, using its in vivo behavioral approach to drug discovery, identified that the compound could be useful in the treatment of ADHD.

About Attention-Deficit Hyperactivity Disorder (ADHD)

ADHD is a neurobehavioral developmental disorder affecting about 3-5% of the world’s population under the age of 19. It typically presents itself during childhood, and is characterized by a persistent pattern of inattention and/or hyperactivity, as well as forgetfulness, poor impulse control or impulsivity, and distractibility. There is a clear need for new non-stimulant therapies for ADHD, currently considered to be a persistent and chronic condition for which no medical cure is available. ADHD is one of the most common psychiatric disorders in children and adolescents with approximately 7.8 percent of all U.S. school-age children, or about 4.4 million children aged 4 to 17 years, having been diagnosed with ADHD at some point in their lives, according to the U.S. Centers for Disease Control and Prevention (CDC). Over 8 million adults in the US also exhibit the symptoms of ADHD, while only an estimated 600,000 are being treated. The ADHD market is valued at over $ 3.5 billion dollars, with approximately 35 million prescriptions written annually.

About PsychoGenics

PsychoGenics is a leader in preclinical behavioral neurobiology. The Company applies its behavioral expertise together with advances in robotics, computer vision, and informatics to provide innovative solutions for central nervous system drug discovery. PsychoGenics works with pharmaceutical and biotechnology companies, academic institutions, and not-for-profit research foundations to help discover treatments for such major neurological and psychiatric disorders as: ALS, anxiety, cognitive impairment, depression, Huntingtons Disease, psychosis/schizophrenia, and SMA. The Company’s in house discovery efforts have focused on psychiatric indications.







Find More Attention Deficit Hyperactivity Disorder Press Releases

Read More

CME Outfitters Announces New neuroscienceCME Live and On Demand Broadcast: ‘Addressing Barriers to Care: Strategies for the Management of Patients with Schizophrenia’

August 06, 2012     No comments

Rockville, MD (PRWEB) November 23, 2009

CME Outfitters, LLC, (CMEO) an award-winning accredited provider of multidisciplinary continuing education (CE), in co-sponsorship with Indiana University School of Medicine and CME LLC, is pleased to announce an upcoming interactive, evidence-based neuroscienceCME Live and On Demand continuing education activity titled “Addressing Barriers to Care: Strategies for the Management of Patients with Schizophrenia.”

Offered as a simultaneous satellite broadcast, webcast, and telephone audioconference premiering Wednesday, December 16, 2009, from 12:00 p.m.-1:00 p.m. ET, the activity will offer clinicians optimal strategies to more effectively manage individuals with schizophrenia across the continuum of care. This activity also includes a special “After the Show” segment from 1:00 p.m.-1:30 p.m. ET during which the faculty answers additional audience questions in an informal Q&A session. The recorded webcast will re-air from 3:00 p.m.-4:00 p.m. ET. This CE activity will also be available on demand as a webcast, podcast, and telephone audioconference shortly after the broadcast premiere.

There is no fee to participate or receive CE credit for this activity; however, registration is required. Three forms of registration are accepted:

Online: Visit the activity details page at http://www.neuroscienceCME.com/PR400 and click the Register for Live Webcast icon.

Phone: Call 877.CME.PROS (877.263.7767).

Fax: Visit the activity details page at http://www.neuroscienceCME.com/PR400, print and complete the activity details form, and fax to 240.243.1033.

Statement of Need:

Until the past decade, there was generally a pessimistic attitude about the treatment of patients with schizophrenia and their outcomes. One key concept that has been identified as critical in optimizing the care and outcomes of patients is continuity of care by a team of healthcare providers. Continuity of care is widely viewed as a key quality indicator for outpatient mental health care and is essential to prevention of relapse and re-hospitalization.

Yet, progress has lagged in the implementation and measurement of continuity of care in clinical practice. In a recent educational activity by CME Outfitters, over 220 psychiatrists responded that their main reason for not changing practice immediately regarding continuity of care was they did not know where to start, demonstrating a gap in knowledge and performance regarding the implementation of this process in clinical practice. A first step to improving care is identifying the barriers that exist. Patient barriers, physician barriers and system barriers can be significant obstacles requiring education of the entire mental healthcare team in order to begin to break down the walls and allow clinicians to provide the best care for each patient.

The identification of the barriers can be the first step in empowering both the provider and the patient. This can highlight to psychiatrists, other healthcare providers, payors, and healthcare systems what barriers may exist and how they are impacting the outcomes and lives of patients.

In this neuroscienceCME Live and On Demand activity, faculty will highlight barriers to optimal care and their impact on the outcomes and lives of patients with schizophrenia and propose practical strategies and tools that can be utilized to improve the care of patients with schizophrenia.

Moderator:

John W. Newcomer, MD

Gregory B. Couch Professor of Psychiatry, Psychology and Medicine

Director, Clinical Trials Unit, Institute of Clinical and Translational Sciences (ICTS)

Director, Regulatory Support Center, ICTS

Medical Director, Center for Clinical Studies

Washington University School of Medicine

St. Louis, MO

Faculty:

Henry A. Nasrallah, MD

Professor of Psychiatry and Neuroscience

University of Cincinnati College of Medicine

Cincinnati, OH

Dawn I. Velligan, PhD

Professor and Co-Director

Division of Schizophrenia and Related Disorders

Department of Psychiatry

The University of Texas Health Science Center at San Antonio

San Antonio, TX

Learning Objectives:

At the end of this CE activity, participants should be able to:

Assess key barriers in practice that impact continuity of care in the management of patients with schizophrenia.
Implement treatment plans in concordance with patients that focus on improving continuity of care.
Incorporate tools and measures in practice to improve discharge transitions of patients with schizophrenia.

Target Audience:

Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals interested in the management of patients with schizophrenia.

Financial Support:

This CME/CE-certified activity is supported by an educational grant from Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.

Credit Information:

This activity offers CE credit for:

Physicians (ACCME/AMA PRA Category 1)
Nurses (CNE)
Pharmacists (ACPE)
Psychologists (APA)
Social Workers (NASW)
Certified Case Managers (CCMC)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.

Credit Expiration Date: Thursday, December 16, 2010

Post-tests, credit request forms, and activity evaluations can be completed online at neuroscienceCME.com (click on the Testing/Certification link under the Activities tab–requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). Otherwise, participants should fully complete and return both the credit request form and activity evaluation located within the course guide for this activity. A certificate or statement of credit will be mailed within 4-6 weeks to all who successfully complete these requirements.

About CME Outfitters:

CME Outfitters develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www.cmeoutfitters.com, http://www.neuroscienceCME.com, or call 877.CME.PROS (877.263.7767).

About neuroscienceCME:

neuroscienceCME.com is the award-winning web portal serving clinicians, educators, and researchers in the neurosciences. Launched in October 2006, neuroscienceCME.com was custom designed to fill an identified gap in online resources for professionals around the world who are practicing in areas related to psychiatry, sleep disorders, addiction and substance abuse, ADHD, and other areas related to brain function. The site’s primary mission is to be the professional’s central forum for accessing, debating, synthesizing, and implementing the latest findings and best practices in the neurosciences. Clinical Compass?, a bi-weekly e-newsletter published by CME Outfitters, is a convenient way to stay informed of all neuroscienceCME news and information. To subscribe, visit http://www.neuroscienceCME.com and click on “Subscribe to Clinical Compass?.”

About neuroscienceCME Live and On Demand:

neuroscienceCME Live and On Demand is a one-hour, live, interactive CE activity offering cutting-edge insights from national experts and clinicians to physicians and healthcare providers in their home, office, or healthcare setting. Utilizing multiple levels of technology (webcast, satellite, and telephone), the panel discussion encourages interaction, reviews real-world scenarios, and shares best practices to improve patient care. An extended 30-minute “After the Show” segment has the faculty remain on the set to answer additional participant questions, address challenging cases, and focus on providing tools for clinicians to improve their practice. Live web-based instant polling allows participants an additional opportunity to provide real-time feedback regarding issues clinicians face in practice. CE certificates are available to participants at neuroscienceCME.com upon completion of each activity. Special Archive Drive dates following the premiere date target registrants who were unable to attend. On demand webcasts and podcasts are available at neuroscienceCME.com for one year after the premiere date. Podcasts are also available in the Science & Medicine directory of iTunes.

Contact: Jessica Primanzon

CME Outfitters, LLC

240.243.1308 direct

240.243.1033 fax

###







Read More

Umbrellas Hawaii Announces an Arc of Sun Protection for Globally Endangered Skin

August 06, 2012     No comments


Honolulu, Hawaii (PRWEB) September 16, 2008

Umbrellas Hawaii steps up to the challenge of global warming with sun blocking umbrellas, as earth’s natural protective shield, the stratospheric ozone layer, is being destroyed.

The Royal Society of Chemistry on April 21, 2008 released ”Global warming cancer warning,” which states, “Global warming could lead to higher rates of skin cancer by amplifying the harmful effects of the sun’s rays.”

“As many as 66,000 people a year die from too much sun, mostly malignant skin cancer,” reports the World Health Organization.

Owner and designer of Umbrellas Hawaii, Annie O’Connor Hughes experienced several incidences of basal cell carcinoma, a type of skin cancer, from 1998-2004. Living in a tropical climate where the average UV index is above 10 daily, she needed serious sun protection. As an alternative to sun block lotions and big hats, she created “island style” sun blocking umbrellas, which are tested and certified to block 97% of UV radiation.

It is estimated that a 10% decrease in ozone levels will result in an additional 300,000 non-melanoma and 4,500 melanoma skin cancers per year. Clearly a focus must be placed on adaptation to global warming. Shade is the recommended prescription from dermatologists worldwide. Sun shade has been a concern for thousands of years, with the umbrella originally created for sun protection as early as 2000 B.C.

Fast forward to today’s ozone diminishing world, and see this ancient invention become a current arc of protection. Umbrellas Hawaii combines exotic island prints with the latest UPF (ultra violet protective factor) fabrics, which offers a powerful sun shield.

“I wanted to create a sun umbrella/parasol that was fun and sassy for today’s sun savvy who are seeking powerful UV protection,” states Annie O’Connor Hughes. Offering a rainbow selection of tropical prints, such as “Golden Sunshine,” “Red Lava,” “Hot Pink Salsa,” “Raspberry Tea” and “Macadamia Nut Tan,” and lining them with color complimenting UPF fabrics, Umbrellas Hawaii provides a powerful accessory for any skin care regimen.

The good news is skin cancer is preventable simply by avoiding the sun. Use technologies latest advances in sun blocking tools, such as UPF fabrics, which are used in clothing, sun umbrellas/parasols, and hats. Know the UV index for your neighborhood on the planet, which forecasts ozone levels in relation to incoming UV radiation levels. The higher the UV index rating, the greater the risk for skin and eye damage.

Umbrellas Hawaii are sold on http://www.umbrellashawaii.com for $ 70.00, and in Hawaii at several island resort wear shops, and art & design gift shops, which are listed on the website.

Skin cancers are in epidemic proportions worldwide. For more sun protection information visit the following websites: Cancer.org, CDC.gov, AAD.org, WHO.int, EPA.gov.

For more information on Umbrellas Hawaii visit http://www.umbrellashawaii.com or call Annie O’Connor Hughes at (808) 943-6238.

###





Read More

Cardiometabolic Health Congress Announces 2013 Cardiometabolic Week

August 05, 2012     No comments

Boston, MA (PRWEB) July 11, 2012

Due to an unprecedented demand from the medical community, the Cardiometabolic Health Congress (CMHC), the premier multidisciplinary congress providing the best cardiometabolic science and clinical education, has expanded its educational program and is pleased to announce the 2013 Cardiometabolic Week, October 2?5, 2013, in Boston, MA. As new treatment modalities for cardiovascular, metabolic, and related comorbidities progress from bench to bedside, the CMHC has expanded its educational initiative to continue to lead the way in translating cutting-edge science into real-world practical solutions that make a significant impact on clinical practice and patient outcomes.

The CMHC has experienced extraordinary growth?including a significant increase in participant registration, association and publication support, and demand for additional scientific sessions to cover the breadth and depth of cardiometabolic-related disorders, as well as a considerable amount of growth in corporate-supported symposia and non-CME sessions. ?For the CMHC to continue to provide the much-needed expert-level education to meet the demand from the multiple specialties engaged in treating cardiometabolic disorders, we definitely outgrew our current congress format; and to accommodate such demand, adding additional time dedicated to education was imperative,? said Dina Kouveliotes, managing director of the CMHC.

?It is striking that the CMHC has become the undisputed leader in conferences that address the most important metabolic derangements of our time, due largely to the strength of the faculty and their interactions with an engaged audience,? said James Gavin III, MD, PhD, CEO, chief medical officer of Healing Our Village Inc., and clinical professor of medicine, Emory University School of Medicine.

The CMHC is supported by 32 prestigious medical societies representing multiple specialties, including the American College of Cardiology, American Heart Association, The Endocrine Society, the World Heart Federation, American Society of Bariatric Physicians, National Kidney Foundation, American Society of Hypertension, and the American Academy of Pediatrics, among many others.

The 7th Annual CMHC, featuring 59 world-renowned expert faculty, 15 scientific sessions, 14 corporate-supported and corporate-sponsored symposia, and approximately 30 CME credit hours, will convene October 10?13, 2012, in Boston, MA, and is co-chaired by George L. Bakris, MD; Christie M. Ballantyne, MD; Robert H. Eckel, MD; and Jay S. Skyler, MD, MACP. The CMHC provides the most advanced-level cardiometabolic education encompassing a multitude of risk factors, including obesity, type 2 diabetes, cardiovascular disease, dyslipidemia, atherosclerosis, hypertension, thrombosis, acute coronary syndrome, chronic kidney disease, and related comorbidities.

For more information, contact Brittany Henry at info(at)cardiometabolichealth(dot)org or 877.571.4700 or visit http://www.cardiometabolichealth.org.







Read More

Addiction Medicine Pioneer Dr. A.R. Mohammad Announces Crucial Summit To Discuss FDA Painkiller-Safety Plan With Industry Leaders

August 03, 2012     No comments


Malibu, CA (PRWEB) July 17, 2012

Dr. Akikur Mohammad, Founder of Malibu Horizon, recognized by many as one of the top addiction treatment centers in California, and Assistant Clinical Professor of Psychiatry and the Behavioral Sciences at the University of Southern California, announced today that he and his team will be adding news of the FDA?s recent painkiller-safety plan to the list of topics being discussed during Malibu Horizon?s upcoming educational summit for addiction experts. Unfortunately, the FDA?s plan to deal with painkiller-safety is not what many experts hoped for. While the plan does involve providing mandatory educational courses for physicians about prescription practices, it does not mandate that physicians take the courses, only that the more than 20 companies that produce extended-release painkillers provide grants to make such courses available free or at a nominal cost.

Dr. Mohammad said, ?Frankly, I am saddened and quite disappointed with the FDA?s proposed plan. While it is certainly a step in the right direction, it still doesn?t make prescription education mandatory at a time when heightened physician awareness is mission critical. Instead, the plan simply asks companies that produce certain painkiller manufacturers to underwrite the courses in hopes of attracting more doctors with lower course fees. In my humble opinion, the FDA has failed all of us by taking such a soft approach to solving a problem that has never been this deadly.? Mohammad added, ?While the FDA says that the programs can only be optional for now and simply cannot be mandatory until a new law is passed by Congress, I doubt the intensity with which the FDA is working with the powers that be to effectively and rapidly make the necessary congressional changes.?

Dr. Mohammad and the Malibu Horizon?s team are adding news of the FDA?s recent painkiller-safety plan to the list of topics being discussed during the team?s upcoming educational summit for addiction experts, with the intention of creating a more private sector approach to mandatory physician education. Mohammad added, ?As responsible physicians, it is painfully clear that the onus is on us to take control of the situation. We have the passion and manpower to implement a series education options for both physicians and civilians that we provide privately and monitor publicly. Patients need to know which doctors are working to be better informed and ultimately committed to solving the problem. Would anyone want to put their lives in the hands of a physician who wasn?t staying as informed as possible? Prescription medication is killing more people than ever before and the addiction community must elevate awareness on all fronts before it is too late. We simply don?t have the time to wait for the FDA and Congress to make a change, it must come from within the team on the frontlines.?

For more information about Dr. Akikur Mohammad, alcoholism treatment and Malibu Horizon, visit http://www.malibuhorizon.com.







Find More Alcoholism Press Releases

Read More
« Older posts
Powered by WordPress | Designed by: best suv | Thanks to toyota suv, infiniti suv and lexus suv